CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) shares in Thousands, $ in Thousands |
Total |
Common Stock |
Treasury Stock |
Paid-in Capital |
Accumulated Other Comprehensive Income/(Loss), net of tax |
Accumulated Deficit |
Beginning balance (in shares) at Dec. 25, 2022 |
|
20,449
|
|
|
|
|
Beginning balance at Dec. 25, 2022 |
$ 1,789
|
$ 20
|
$ (182,810)
|
$ 238,803
|
$ (34)
|
$ (54,190)
|
Beginning balance (in shares) at Dec. 25, 2022 |
|
|
4,515
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
(129)
|
|
|
|
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
224
|
|
$ 5,330
|
(5,106)
|
|
|
Non-cash stock compensation |
2,179
|
|
|
2,179
|
|
|
Net Income (Loss) |
(3,256)
|
|
|
|
|
(3,256)
|
Other comprehensive income (loss), net of tax |
8
|
|
|
|
8
|
|
Ending balance (in shares) at Apr. 16, 2023 |
|
20,449
|
|
|
|
|
Ending balance at Apr. 16, 2023 |
944
|
$ 20
|
$ (177,480)
|
235,876
|
(26)
|
(57,446)
|
Ending balance (in shares) at Apr. 16, 2023 |
|
|
4,386
|
|
|
|
Beginning balance (in shares) at Dec. 25, 2022 |
|
20,449
|
|
|
|
|
Beginning balance at Dec. 25, 2022 |
1,789
|
$ 20
|
$ (182,810)
|
238,803
|
(34)
|
(54,190)
|
Beginning balance (in shares) at Dec. 25, 2022 |
|
|
4,515
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Net Income (Loss) |
(7,496)
|
|
|
|
|
|
Other comprehensive income (loss), net of tax |
1
|
|
|
|
|
|
Ending balance (in shares) at Oct. 01, 2023 |
|
20,449
|
|
|
|
|
Ending balance at Oct. 01, 2023 |
(8,743)
|
$ 20
|
$ (176,813)
|
229,769
|
(34)
|
(61,685)
|
Ending balance (in shares) at Oct. 01, 2023 |
|
|
4,967
|
|
|
|
Beginning balance (in shares) at Apr. 16, 2023 |
|
20,449
|
|
|
|
|
Beginning balance at Apr. 16, 2023 |
944
|
$ 20
|
$ (177,480)
|
235,876
|
(26)
|
(57,446)
|
Beginning balance (in shares) at Apr. 16, 2023 |
|
|
4,386
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
(250)
|
|
|
|
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
1,636
|
|
$ 9,933
|
(8,297)
|
|
|
Acquisition of treasury stock (in shares) |
|
|
382
|
|
|
|
Acquisition of treasury stock |
(4,999)
|
|
$ (4,999)
|
|
|
|
Non-cash stock compensation |
1,519
|
|
|
1,519
|
|
|
Net Income (Loss) |
3,922
|
|
|
|
|
3,922
|
Other comprehensive income (loss), net of tax |
4
|
|
|
|
4
|
|
Ending balance (in shares) at Jul. 09, 2023 |
|
20,449
|
|
|
|
|
Ending balance at Jul. 09, 2023 |
3,026
|
$ 20
|
$ (172,546)
|
229,098
|
(22)
|
(53,524)
|
Ending balance (in shares) at Jul. 09, 2023 |
|
|
4,518
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
(31)
|
|
|
|
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
(115)
|
|
$ 694
|
(809)
|
|
|
Acquisition of treasury stock (in shares) |
|
|
480
|
|
|
|
Acquisition of treasury stock |
(4,961)
|
|
$ (4,961)
|
|
|
|
Non-cash stock compensation |
1,480
|
|
|
1,480
|
|
|
Net Income (Loss) |
(8,161)
|
|
|
|
|
(8,161)
|
Other comprehensive income (loss), net of tax |
(12)
|
|
|
|
(12)
|
|
Ending balance (in shares) at Oct. 01, 2023 |
|
20,449
|
|
|
|
|
Ending balance at Oct. 01, 2023 |
$ (8,743)
|
$ 20
|
$ (176,813)
|
229,769
|
(34)
|
(61,685)
|
Ending balance (in shares) at Oct. 01, 2023 |
|
|
4,967
|
|
|
|
Beginning balance (in shares) at Dec. 31, 2023 |
15,528
|
20,449
|
|
|
|
|
Beginning balance at Dec. 31, 2023 |
$ (20,442)
|
$ 20
|
$ (174,702)
|
229,680
|
(22)
|
(75,418)
|
Beginning balance (in shares) at Dec. 31, 2023 |
4,921
|
|
4,921
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
(84)
|
|
|
|
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
$ (371)
|
|
$ 3,011
|
(3,382)
|
|
|
Non-cash stock compensation |
1,190
|
|
|
1,190
|
|
|
Net Income (Loss) |
(9,460)
|
|
|
|
|
(9,460)
|
Other comprehensive income (loss), net of tax |
(18)
|
|
|
|
(18)
|
|
Ending balance (in shares) at Apr. 21, 2024 |
|
20,449
|
|
|
|
|
Ending balance at Apr. 21, 2024 |
$ (29,101)
|
$ 20
|
$ (171,691)
|
227,488
|
(40)
|
(84,878)
|
Ending balance (in shares) at Apr. 21, 2024 |
|
|
4,837
|
|
|
|
Beginning balance (in shares) at Dec. 31, 2023 |
15,528
|
20,449
|
|
|
|
|
Beginning balance at Dec. 31, 2023 |
$ (20,442)
|
$ 20
|
$ (174,702)
|
229,680
|
(22)
|
(75,418)
|
Beginning balance (in shares) at Dec. 31, 2023 |
4,921
|
|
4,921
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Net Income (Loss) |
$ (37,825)
|
|
|
|
|
|
Other comprehensive income (loss), net of tax |
$ (12)
|
|
|
|
|
|
Ending balance (in shares) at Oct. 06, 2024 |
15,779
|
20,449
|
|
|
|
|
Ending balance at Oct. 06, 2024 |
$ (53,337)
|
$ 20
|
$ (165,747)
|
225,666
|
(33)
|
(113,243)
|
Ending balance (in shares) at Oct. 06, 2024 |
4,670
|
|
4,670
|
|
|
|
Beginning balance (in shares) at Apr. 21, 2024 |
|
20,449
|
|
|
|
|
Beginning balance at Apr. 21, 2024 |
$ (29,101)
|
$ 20
|
$ (171,691)
|
227,488
|
(40)
|
(84,878)
|
Beginning balance (in shares) at Apr. 21, 2024 |
|
|
4,837
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
(143)
|
|
|
|
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
187
|
|
$ 5,106
|
(4,919)
|
|
|
Non-cash stock compensation |
1,856
|
|
|
1,856
|
|
|
Net Income (Loss) |
(9,489)
|
|
|
|
|
(9,489)
|
Other comprehensive income (loss), net of tax |
4
|
|
|
|
4
|
|
Ending balance (in shares) at Jul. 14, 2024 |
|
20,449
|
|
|
|
|
Ending balance at Jul. 14, 2024 |
(36,543)
|
$ 20
|
$ (166,585)
|
224,425
|
(36)
|
(94,367)
|
Ending balance (in shares) at Jul. 14, 2024 |
|
|
4,694
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
(24)
|
|
|
|
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
(59)
|
|
$ 838
|
(897)
|
|
|
Non-cash stock compensation |
2,138
|
|
|
2,138
|
|
|
Net Income (Loss) |
(18,876)
|
|
|
|
|
(18,876)
|
Other comprehensive income (loss), net of tax |
$ 3
|
|
|
|
3
|
|
Ending balance (in shares) at Oct. 06, 2024 |
15,779
|
20,449
|
|
|
|
|
Ending balance at Oct. 06, 2024 |
$ (53,337)
|
$ 20
|
$ (165,747)
|
$ 225,666
|
$ (33)
|
$ (113,243)
|
Ending balance (in shares) at Oct. 06, 2024 |
4,670
|
|
4,670
|
|
|
|